Clinical trial
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
NCT00115453 · Boneca Corporation, Industry · Terminated
Key facts
| NCT number | NCT00115453 |
|---|---|
| Title | Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma |
| Official title | Boron Neutron Capture Therapy in the Treatment of Glioblastoma Multiforme |
| Lead sponsor | Boneca Corporation, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma |
| Intervention type | Radiation |
| Interventions | irradiation |
| Enrollment | 50 |
| Start date | May 1, 1999 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jun 23, 2005 |
| Last update posted | Aug 18, 2008 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: